Home / Inspections / 1231030

FDA Inspection 1231030 — Central California Blood Center

Central California Blood Center — FEI 2970009

The FDA completed an inspection of Central California Blood Center on February 14, 2024 in Visalia, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 14, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Visalia, CA (United States)

Facility

Other inspections at this facility

  • 1086315 (NAI Mon Apr 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 999728 (NAI Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 926973 (NAI Mon May 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 829793 (NAI Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 728253 (NAI Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources